News Coverage 08.05.19 By: John Carroll Share on Twitter Share on Facebook Share on LinkedIn Close to a decade after Eli Lilly killed it, Jeffrey Bluestone’s ‘breakthrough’ drug is back and being steered to the FDA Related Announcement PICI Network at #SITC23 Announcement, Our Impact PICI Network Members at #AACRtii23 Announcement PICI Welcomes New UCSF Center Director